GlassScriptPhysician profile
Wade M Sessions
NPI 1659483816
$12,745.09
in general payments reported to CMS, 2019-2025
18 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,067 · 2020: $3,885 · 2021: $2,804 · 2022: $2,187 · 2023: $353 · 2024: $283 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $6,152.11 | 2019-2024 | |
| Stryker Corporation | $3,538.46 | 2019-2024 | Mako, Blueprint Patient Specific Instrumentation |
| Arthrex, INC. | $1,750.65 | 2020-2022 | |
| Orthalign INC | $245.00 | 2019-2024 | Orthalign Plus |
| Zimmer Biomet Holdings, INC. | $186.40 | 2019-2025 | Samples Biologics |
| Lima USA, INC. | $178.37 | 2019 | |
| Smith+Nephew, INC. | $177.64 | 2019-2021 | |
| Depuy Synthes Sales INC. | $140.27 | 2021-2024 | Na |
| Merck Sharp & Dohme LLC | $96.68 | 2022-2024 | Bridion |
| Boston Scientific Corporation | $65.67 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Ferring Pharmaceuticals INC. | $42.69 | 2019-2020 | |
| Haemonetics Corporation | $40.14 | 2020-2021 | |
| Anika Therapeutics, INC. | $38.46 | 2021-2023 | Ovomotion |
| Biocomposites INC | $33.81 | 2025 | Stimulan |
| Vertex Pharmaceuticals Incorporated | $16.71 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $15.24 | 2020 | |
| Amgen INC. | $15.20 | 2019 | |
| Davol INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Sessions listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.